Journal
ALZHEIMERS & DEMENTIA
Volume 10, Issue 1, Pages 109-114Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2013.10.007
Keywords
Alzheimer's disease; Early diagnosis; Early detection; Blood based biomarker; Biomarker; Diagnostics
Categories
Funding
- Medical Research Council [G0801464] Funding Source: Medline
- NIEHS NIH HHS [R01 ES020715] Funding Source: Medline
- MRC [G0801464] Funding Source: UKRI
- Alzheimers Research UK [ARUK-EXT2013-4] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0512-10053] Funding Source: researchfish
- NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020715] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a widely available, inexpensive and reliable method to diagnosis Alzheimer's disease in the earliest stages, track disease progression, and accelerate clinical development of new therapeutics. One avenue of research being explored is blood based biomarkers. In April 2012, the Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened top scientists from around the world to discuss the state of blood based biomarker development. This manuscript summarizes the meeting and the resultant discussion, including potential next steps to move this area of research forward. (C) 2014 The Alzheimer's Association. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
